Been there, not done that--melanoma in the age ... [N Engl J Med. 2011] - PubMed

loading

Melanoma--an unlikely poster child for personalized cancer therapy. [N Engl J Med. 2010]
Melanoma--an unlikely poster child for personalized cancer therapy.
Smalley KS, Sondak VK. N Engl J Med. 2010 Aug 26; 363(9):876-8.
Strides in melanoma announced: maximizing value comes next. [J Natl Cancer Inst. 2011]
Strides in melanoma announced: maximizing value comes next.
Tuma RS. J Natl Cancer Inst. 2011 Jul 6; 103(13):997-9. Epub 2011 Jun 21.
Vemurafenib. [Nat Rev Drug Discov. 2011]
Vemurafenib.
Flaherty KT, Yasothan U, Kirkpatrick P. Nat Rev Drug Discov. 2011 Oct 31; 10(11):811-2. Epub 2011 Oct 31.
Review PLX-4032, a small-molecule B-Raf inhibitor for the potential treatment of malignant melanoma. [Curr Opin Investig Drugs. 2010]
Review PLX-4032, a small-molecule B-Raf inhibitor for the potential treatment of malignant melanoma.
Smalley KS. Curr Opin Investig Drugs. 2010 Jun; 11(6):699-706.
Review Vemurafenib: the road to personalized medicine in melanoma. [Drugs Today (Barc). 2012]
Review Vemurafenib: the road to personalized medicine in melanoma.
Amaria RN, Lewis KD, Jimeno A. Drugs Today (Barc). 2012 Feb; 48(2):109-18.

Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation. [Cancer Manag Res. 2012]
Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation.
Coventry BJ, Ashdown ML. Cancer Manag Res. 2012; 4:137-49. Epub 2012 May 28.
Review Adjunct primer for the use of national comprehensive cancer network guidelines for the surgical management of cutaneous malignant melanoma patients. [World J Surg Oncol. 2012]
Review Adjunct primer for the use of national comprehensive cancer network guidelines for the surgical management of cutaneous malignant melanoma patients.
Silva E. World J Surg Oncol. 2012 Apr 6; 10:54. Epub 2012 Apr 6.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Been there, not done that--melanoma in the age of molecular therapy.
Been there, not done that--melanoma in the age of molecular therapy.
N Engl J Med. 2011 Jun 30 ;364(26):2547-8. doi: 10.1056/NEJMe1105792. Epub 2011 Jun 5 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed